Your browser doesn't support javascript.
loading
Autocrine INSL5 promotes tumor progression and glycolysis via activation of STAT5 signaling.
Li, Shi-Bing; Liu, Yan-Yan; Yuan, Li; Ji, Ming-Fang; Zhang, Ao; Li, Hui-Yu; Tang, Lin-Quan; Fang, Shuo-Gui; Zhang, Hua; Xing, Shan; Li, Man-Zhi; Zhong, Qian; Lin, Shao-Jun; Liu, Wan-Li; Huang, Peng; Zeng, Yi-Xin; Zheng, Yu-Ming; Ling, Zhi-Qiang; Sui, Jian-Hua; Zeng, Mu-Sheng.
Afiliação
  • Li SB; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Liu YY; Department of Nephrology, Division of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Yuan L; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Ji MF; Cancer Research Institute of Zhongshan City, Zhongshan, China.
  • Zhang A; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Li HY; National Institute of Biological Sciences, Beijing, China.
  • Tang LQ; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Fang SG; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Zhang H; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Xing S; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Li MZ; School of Medicine, Sun Yat-sen University, Guangzhou, China.
  • Zhong Q; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Lin SJ; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Liu WL; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Huang P; Department of Radiation Oncology, Fujian Provincial Cancer Hospital, Fuzhou, China.
  • Zeng YX; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Zheng YM; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Ling ZQ; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Sui JH; Department of Clinical Laboratory, Wuzhou Red Cross Hospital, Wuzhou, China.
  • Zeng MS; Zhejiang Cancer Hospital, Hangzhou, China.
EMBO Mol Med ; 12(9): e12050, 2020 09 07.
Article em En | MEDLINE | ID: mdl-32657028

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Nasofaríngeas / Fator de Transcrição STAT5 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: EMBO Mol Med Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Nasofaríngeas / Fator de Transcrição STAT5 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: EMBO Mol Med Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China
...